Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited announces UBS Group AG as a substantial holder with a 5.97% voting power, effective August 21, 2024. UBS Securities Australia Ltd is both the beneficial owner and the registered holder of 114,376,345 ordinary shares. The detailed considerations for the transactions preceding this change in holding are provided in Appendix A of the original document.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
